Notably, SCN5A DCM with frequent multifocal PVCs responds well to antiarrhythmic therapy: in one series, 87% (20 of 23) of patients treated with sodium channel blockers showed complete resolution of PVCs and normalization of LVEF [10]. This evidence concerns the gene SCN5A and ventricular ectopy.